New drug aims to wipe out hidden cancer cells in head and neck cancer survivors
NCT ID NCT05414032
First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study tests a drug called AZD2936 in about 100 people with high-risk head and neck cancer who still have signs of cancer DNA in their blood after standard treatment. The goal is to see if the drug can clear those cancer signals and prevent the cancer from coming back. Participants will either receive the drug or standard monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCOREGIONALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Canada
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.